Sector News

Report: Private equity firms eyeing Bayer MaterialScience

October 23, 2014
Energy & Chemical Value Chain
Private equity firms are mulling possible offers for Bayer MaterialScience (BMS), the German life science company’s major polyurethanes and polycarbonates business, according to a report on Reuters, citing sources familiar with the situation. Analysts have already speculated that BMS, which could be worth around €10 billion ($12.7 billion) on a debt-free basis when it is separated from Bayer next year, might also attract an industry buyer keen to establish a leadership position in BMS’s value-added plastics markets. 
 
> Read the full article on the Chemical Week website
 
By Natasha Alperowicz
 

comments closed

Related News

February 7, 2025

Air Products appoints Eduardo F. Menezes CEO

Energy & Chemical Value Chain

Air Products recently announced the appointment of Eduardo F. Menezes as Chief Executive Officer (CEO) of Air Products effective February 7, 2025, succeeding Seifollah (“Seifi”) Ghasemi, who is leaving the Company after more than 10 years of dedicated service.

February 7, 2025

Blastr Green Steel completes partner financing round for ultra-low CO2 steel value chain

Energy & Chemical Value Chain

Blastr Green Steel (Blastr) has successfully completed a second strategic partner financing round, advancing the development of a European integrated ultra-low CO2 steel value chain with its flagship steel plant in Finland. The partner financing round included three of Blastr’s founding investors and three new investors based in Finland, all with a common emphasis on sustainable growth.

February 7, 2025

Mitsubishi Chemical sells Mitsubishi Tanabe Pharma to Bain Capital for $3.3B

Energy & Chemical Value Chain

Mitsubishi Chemical Group has signed an agreement to sell its pharmaceutical business Mitsubishi Tanabe Pharma Corp. to Bain Capital (Boston, Massachusetts). The cost of the transaction is ¥510 billion ($3.3 billion). The closing of this transaction is scheduled for the second quarter of 2026, subject to a resolution at the annual shareholders’ meeting scheduled in June 2025.

How can we help you?

We're easy to reach